Reveal Genomics and IEO Collaborate on HER2DX® Test Decision-Making Study

Reveal Genomics, a Barcelona-based biotechnology startup focused on revolutionizing precision oncology through biomarker innovation, has partnered with the European Institute of Oncology (IEO) to launch a groundbreaking impact study on HER2DX®, the world’s first specialized genomic test for HER2+ breast…

Read MoreReveal Genomics and IEO Collaborate on HER2DX® Test Decision-Making Study

Nalu 1-Year PNS Data Show Lasting Pain Relief and Functional Improvement

One-year data from the Nalu COMFORT randomized controlled trial (RCT), published in Regional Anesthesia & Pain Medicine, confirms the long-lasting effectiveness of Nalu’s peripheral nerve stimulation (PNS) technology in providing durable pain relief and significant functional improvement. The findings, which…

Read MoreNalu 1-Year PNS Data Show Lasting Pain Relief and Functional Improvement

Two-Year Data Shows Vista Cardiac Offers Faster, More Reliable MRI Scans

Vista, a leader in intelligent MRI acquisition software, has announced two-year clinical results demonstrating that Vista Cardiac enhances workflow efficiency, delivers high-quality and consistent imaging, and helps scale cardiac MRI (CMR) programs, increasing patient access. Dr. Raymond Kwong, Director of…

Read MoreTwo-Year Data Shows Vista Cardiac Offers Faster, More Reliable MRI Scans

Accellix Platform Chosen by American Red Cross for Cell Therapy Material Characterization

The American Red Cross’s Cell and Gene Therapy Solutions (CGTS) division, a leading provider of allogeneic cell therapy materials, has selected Accellix, Inc. to supply its automated flow cytometry platform for point-of-need testing. Accellix instruments and assays will be used…

Read MoreAccellix Platform Chosen by American Red Cross for Cell Therapy Material Characterization

Lightbeam Health, Primary Partners, and Alliance for Community Health Win 2024 KLAS SDOH Award

Lightbeam Health Solutions, a leader in population health technology, Primary Partners, a Florida-based organization of over 750 independent physicians, and Alliance for Community Health (AFCH), a Florida nonprofit, have been honored with the 2024 SDOH Points of Light recognition by…

Read MoreLightbeam Health, Primary Partners, and Alliance for Community Health Win 2024 KLAS SDOH Award

Janux Selects Doses for Phase 1b Trials of JANX007 in mCRPC Following Positive Phase 1a Results

Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing innovative immunotherapies, announced positive interim clinical data for its JANX007 program in metastatic castration-resistant prostate cancer (mCRPC). The company will host a virtual event today at 4:30 PM ET to…

Read MoreJanux Selects Doses for Phase 1b Trials of JANX007 in mCRPC Following Positive Phase 1a Results

Radiology Partners and RADPAIR Form Strategic Partnership for Generative AI in Radiology

Radiology Partners (RP), the leading radiology practice in the U.S., and RADPAIR, a leader in generative AI-driven radiology solutions, have announced a strategic partnership aimed at advancing innovation in radiology and tackling critical capacity challenges. The collaboration will focus on…

Read MoreRadiology Partners and RADPAIR Form Strategic Partnership for Generative AI in Radiology

Hologic Presents Research on Breast Imaging AI’s Consistent Performance Across Diverse Populations

Hologic, Inc. (Nasdaq: HOLX) presented new research at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), showcasing the performance of its Genius AI® Detection 2.0 software across diverse patient populations. Artificial intelligence (AI)…

Read MoreHologic Presents Research on Breast Imaging AI’s Consistent Performance Across Diverse Populations